Back to Agenda
Implementable Approaches to Fully Integrating Patient Engagement Across an Entire Company: Including all Clinical Trials
Session Chair(s)
Victoria DiBiaso, BSN, MPH, RN
Global Head, Patient Informed Development and Health Value Translation
Sanofi, France
Increasingly, biopharmas are integrating patient engagement across their corporations in ways that address shared priorities with patient communities. Additionally, they are also increasing the transparency related to delivering on these commitments, including but not limited to, the percent of clinical trials that are informed by patients. This workshop will discuss approaches taken by various companies, the role of advocates, and their perspectives on the importance of achieving meaningful patient engagement, along with the steps necessary to achieve the goals.
Learning Objective : Describe how to bring together key stakeholders to evaluate how, and where, patient engagement can be fully integrated to address what matters most to patients; Describe how to move beyond patients informing select clinical trials to 100% of a portfolio; Identify how to align resources, capabilities and change management needs to deliver on the vision; Discuss how to communicate and monitor the impact of engagement strategies.
Speaker(s)
Implementable Approaches to Fully Integrating Patient Engagement Across an Entire Company: Including all Clinical Trials
Tracey Robertson, MBA
Boehringer Ingelheim Pharmaceuticals Inc., United States
Head of Patient and Site Engagement Capabilities
Patient Perspective
Hollie Schmidt, MS
Accelerated Cure Project, United States
Vice President of Scientific Operations
Have an account?